SCARPELLI, Marina
 Distribuzione geografica
Continente #
NA - Nord America 15.318
EU - Europa 7.471
AS - Asia 3.886
SA - Sud America 562
AF - Africa 263
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 5
Totale 27.524
Nazione #
US - Stati Uniti d'America 15.243
UA - Ucraina 1.552
SG - Singapore 1.275
IE - Irlanda 993
RU - Federazione Russa 980
SE - Svezia 845
IT - Italia 812
HK - Hong Kong 806
TR - Turchia 759
DE - Germania 749
DK - Danimarca 575
CN - Cina 557
BR - Brasile 513
FI - Finlandia 333
KR - Corea 312
GB - Regno Unito 267
FR - Francia 206
CI - Costa d'Avorio 200
IN - India 80
MA - Marocco 38
BE - Belgio 35
MX - Messico 35
CA - Canada 33
NL - Olanda 28
RO - Romania 18
EU - Europa 17
EE - Estonia 16
AT - Austria 14
AR - Argentina 13
JP - Giappone 12
IQ - Iraq 9
PL - Polonia 9
UZ - Uzbekistan 9
EC - Ecuador 8
ID - Indonesia 8
ZA - Sudafrica 8
EG - Egitto 7
PK - Pakistan 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
BO - Bolivia 6
CO - Colombia 6
ES - Italia 6
PE - Perù 6
AU - Australia 5
CZ - Repubblica Ceca 5
KZ - Kazakistan 5
VN - Vietnam 5
AZ - Azerbaigian 4
BD - Bangladesh 4
TN - Tunisia 4
CH - Svizzera 3
IR - Iran 3
KE - Kenya 3
KG - Kirghizistan 3
OM - Oman 3
RS - Serbia 3
AL - Albania 2
AO - Angola 2
CL - Cile 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
LB - Libano 2
LU - Lussemburgo 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 27.524
Città #
Chandler 1.751
Jacksonville 1.634
Fairfield 1.437
Des Moines 1.201
Dublin 993
Ashburn 977
Boardman 901
Wilmington 810
Hong Kong 801
Woodbridge 642
Singapore 613
Seattle 569
Houston 555
New York 459
Cambridge 426
Lawrence 402
Princeton 402
San Mateo 390
Ann Arbor 290
Centro 213
Abidjan 200
Moscow 197
San Diego 177
Milan 162
The Dalles 153
London 84
Pune 73
Beijing 70
Washington 61
Los Angeles 55
Shanghai 54
Redmond 46
Guangzhou 44
Norwalk 44
São Paulo 43
Turin 40
Wuhan 39
Dallas 38
Izmir 37
Brussels 33
Helsinki 33
Mexico City 29
Ancona 28
Falls Church 28
Jiaxing 22
Marche 19
Ottawa 18
Prescot 18
Turku 18
Venice 16
Munich 15
Porto 15
Rio de Janeiro 15
Kilburn 14
Yiwu 14
Seoul 12
Wuxi 12
Chicago 11
Fayetteville 11
Shenzhen 11
Nuremberg 10
Rome 10
Amsterdam 9
Belo Horizonte 9
Chiswick 9
New Bedfont 9
Porto Alegre 9
San Francisco 9
Auburn Hills 8
Curitiba 8
Tashkent 8
Tokyo 8
Campinas 7
Fuzhou 7
Hounslow 7
Modena 7
Montréal 7
Phoenix 7
Strasbourg 7
Torre Del Greco 7
Vienna 7
Warsaw 7
Edinburgh 6
Guarulhos 6
Istanbul 6
Jinhua 6
Redwood City 6
Salvador 6
Santa Clara 6
Wandsworth 6
Ascoli Piceno 5
Cairo 5
Council Bluffs 5
Guayaquil 5
Joinville 5
La Paz 5
Mauá 5
Nanjing 5
Osasco 5
Quanzhou 5
Totale 17.749
Nome #
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 174
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 170
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 146
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 141
Immunotherapy in genitourinary cancers: Where are we going? 139
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 133
Standardized mitotic counts in breast cancer evaluation of the method 127
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 126
Are liver nested stromal epithelial tumors always low aggressive? 124
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 124
Secondary neoplasms of the urinary system and male genital organs. 118
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 116
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 116
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 115
Microbiome and cancers, with focus on genitourinary tumors 114
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 112
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 111
Metabolic phenotype of bladder cancer 111
Computer assisted discrimination of glioblastomas 110
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 107
Angioblastic parasellar extradural tumours. 106
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 105
Rare synchronous association of vestibular schwannoma and indolent insular oligodendroglioma in a patient without neurofibromatosis: controversial issue of timing for surgical treatment of asymptomatic low-grade gliomas. 105
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 104
Meningioma-like cerebral relapse of Hodgkin's disease. 103
2004 WHO classification of the renal tumors of the adults. 101
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 101
Seminoma Retroperitoneal Relapse 23 Years After Surgery 101
Endoscopy-verified occult subependymal dissemination of glioblastoma and brain metastasis undetected by MRI: prognostic significance. 100
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 100
From undergraduate medical school student to visible pathologist 100
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 99
Seminal Vesicle Intraepithelial Neoplasia Versus Basal Cell Hyperplasia in a Seminal Vesicle. 98
Cardiac myxoma with glandular elements metastatic to the brain 12 years after the removal of the original tumor 98
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy 98
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 98
Is There a Role for Immunotherapy in Prostate Cancer? 98
Quantitative-analysis of Prostatic Intraepithelial Neoplasia On Tissue-sections. 97
Morphological diagnosis of urothelial neoplasms. 96
A rare case of chordoma and craniopharyngioma treated by an endoscopic endonasal, transtubercular transclival approach. 96
Metabolic Alterations in Renal and Prostate Cancer 96
The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions 96
Pd-l1 inhibitors for the treatment of prostate cancer 95
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 94
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 94
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 94
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 93
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 93
Computer assisted analysis of medulloblastoma: a cytological study 93
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 93
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 92
Subarachnoid haemorrhage due to widely metastatising malignant ependymoma. 92
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 92
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. 91
TGFb1 immunohistochemistry in goiter; comparison of patients with recurrence or non recurrence 91
Joint appraisal of the radical prostatectomy specimen by the urologist and the uropathologist: together, we can do it better 91
HER family receptor expression and prognosis in pancreatic cancer 91
Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN). 90
SURGICAL TREATMENT FOR GLIOBLASTOMA MULTIFORME: OUTCOME AND ANALYSIS OF PROGNOSTIC FACTORS ESPECIALLY ORIENTED TO THE EXTENT OF SURGICAL RESECTION 90
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers 90
Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? 89
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 89
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 89
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 89
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 89
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 89
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 89
Epileptogenic Low-Grade Tumours in Childhood: Outcome after Lesionectomy 88
Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. 88
Genitourinary cancers: molecular determinants for personalized therapies 88
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 88
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report 88
Granular osmiophilic material-containing pseudoinclusions in CADASIL 88
Epigenetic modifications and modulators in prostate cancer 87
RAS genes in colorectal carcinoma: Pathogenesis, testing guidelines and treatment implications 87
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 87
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 87
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 86
The human microbiota and prostate cancer: Friend or foe? 86
New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen 86
Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there? 86
Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors 85
Extramammary Paget disease of the penis closely mimicking the penile analogue of stratified mucin-producing intraepithelial lesion 85
Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique 84
Active surveillance for low-risk prostate cancer. 84
Noninvasive papillary transitional-cell tumors. Karyometric and DNA-content analysis. 84
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 84
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 84
Immune checkpoint inhibitors for the treatment of bladder cancer 84
Contemporary update on pathology-related issues on routine workup of prostate biopsy: sectioning, tumor extent measurement, specimen orientation, and immunohistochemistry. 83
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 83
Pathology of prostate cancer and focal therapy ('male lumpectomy'). 82
Evaluation of prognostic factors in radical prostatectomy specimens with cancer 82
Pathology and molecular updates in tumors of the prostate: towards a personalized approach. 82
Role of electron microscopy in the diagnosis of CADASIL syndrome: a study of 32 patients 81
CADASIL: ultrastructural insights into the morphology of granular osmiophilic material 81
Renal sarcoma associated with adult polycystic kidney disease. A case report and literature review. 80
Prostatic intraepithelial neoplasia: its morphological and molecular diagnosis and clinical significance. 80
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 80
New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents? 80
Totale 9.800
Categoria #
all - tutte 162.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.269


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020526 0 0 0 0 0 0 0 0 0 0 66 460
2020/20215.738 275 485 689 111 681 722 481 443 495 552 572 232
2021/20223.031 317 620 95 136 28 269 82 202 192 273 190 627
2022/20235.798 523 459 326 462 379 1.580 3 350 1.303 34 267 112
2023/20243.068 555 78 200 429 510 696 53 75 6 53 26 387
2024/20255.055 657 522 240 141 214 222 560 262 1.535 462 240 0
Totale 27.936